Mrs Isabelle Desmas-Bazelle

Lynch S, Halfacree Z, Desmas I, Cahalan SD, Keenihan EK, Lamb CR. -Pulmonary lipoma in a dog. J Small Anim Pract. 2013 Jun 3.
Treggiari E, Ressel L, Polton GA, Benoit J, Desmas I, Blackwood L. - Clinical outcome, PDGFRβ and KIT expression in feline histiocytic disorders: a multicentre study. Vet Comp Oncol 2017 15(1):65-77.
Desmas I, Burton JH, Post G, Kristal O, Gauthier M, Borrego JF, Di Bella A, Lara-Garcia A. Clinical presentation, treatment and outcome in 31 dogs with presumed primary colorectal lymphoma (2001-2013). Vet Comp Oncol 2017 15(2):504-517.
Gommeren K, Desmas I, Garcia A, Bauer N, Moritz A, Roth J, Peeters D. Inflammatory cytokine and C-reactive protein concentrations in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care 2018 28(1):9-19.
Gommeren K, Desmas I, Garcia A, Clercx C, Mc Entee K, Merveille AC, Peeters D. Cardiovascular biomarkers in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio). 2019 29(3):256-263
Purzycka K., Desmas I., Peters L., Lara-Garcia A. Clinicopathological characteristics and prognostic factors for canine multicentric non-indolent T-cell lymphoma: 107 cases. Vet Comp Oncol 2020 18(4):656-663.
Aspinall S., Demas I., Bazelle J. Use of eltrombopag and granulocyte colony-stimulating factor in treatment of lomustine overdose in a dog. Vet Record case reports 2021 9(4)

Prospective evaluation of palliative and adjuvant toceranib phosphate therapy in dogs diagnosed with metastatic or recurrent insulinomas

Insulinomas are the most common tumours of the pancreas in dogs. This multi-institutional prospective study evaluates the effectiveness of the drug toceranib phosphate in the treatment of insulinomas in dogs. This is an observational multi-institutional prospective trial. Client preferences regarding control/treatment group allocation will be followed and enrolment will not be blinded or randomised.

랸한app